Hepatitis C eradication and improvement of cryoglobulinemia-associated rash and membranoproliferative glomerulonephritis with inteferon and ribavirin after kidney transplantation

Canadian Journal of Gastroenterology

Volumn 20, Issue 6, 2006, Pages 427-431

  Zeman, Marilyn ^a   Campbell, Patricia ^a   Bain, Vincent G ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Cryoglobulin; Hepatitis C; Interferon; Kidney transplant

Indexed keywords

ALPHA INTERFERON; CALCITRIOL; CALCIUM CARBONATE; CANDESARTAN HEXETIL; CREATININE; DILTIAZEM; FOSINOPRIL; FUROSEMIDE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; PRAZOSIN; PREDNISONE; RANITIDINE; RECOMBINANT ERYTHROPOIETIN; RIBAVIRIN; TACROLIMUS; TERAZOSIN; VIRUS RNA;

ADULT; ARTICLE; BLOOD TRANSFUSION; CASE REPORT; CLINICAL EXAMINATION; CRYOGLOBULINEMIA; GRAFT RECIPIENT; GRAFT REJECTION; HEMODIALYSIS; HEMOLYTIC ANEMIA; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MALE; MEDICAL DECISION MAKING; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; PATIENT SELECTION; PERITONEAL DIALYSIS; PERITONITIS; PREVALENCE; PRIORITY JOURNAL; PROTEINURIA; RASH; TREATMENT OUTCOME; URINALYSIS;

EID: 33746167483     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2006/301232     Document Type: Article

References (34)

1. Morales JM. Hepatitis C virus infection and renal disease after renal transplantation. Transplant Proc 2004;36:760-2.
2. Manns MP, McHutchison JG, Gordon SC, et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: A randomised trial. Lancet 2001;358:958-65.
3. Fried MW, Shiffman ML, Reddy KR, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002;347:975-82.
4. Fabrizi F, Martin P, Ponticelli C. Hepatitis C virus infection and renal transplantation. Am J Kidney Dis 2001;38:919-34.
5. Garnier JL, Chevallier P, Dubernard JM, Trepo C, Touraine JL, Chossegros P. Treatment of hepatitis C virus infection with ribarivin in kidney transplant patients. Transplant Proc 1997;29:783.
6. Brushfeld A, Stable L, Andersson J, Schvarcz R. Ribavirin treatment in dialysis patients with chronic hepatitis C virus infection - A pilot study. J Viral Hepat 2001;8:287-92.
7. Brushfeld A, Lindahl K, Stahle L, Soderberg M, Schvarcz R. Interferon and ribarivin treatment in patients with hepatitis C-associated renal disease and renal insufficiency. Nephrol Dial Transplant 2003;18:1573-80.
8. Steinhauslin F, Wauters JP. Quantitation of proteinuria in kidney transplant patients: Accuracy of the urinary protein/creatinine ratio. Clin Nephrol 1995;43:110-5.
9. Roth D, Cirocco R, Zucker K, et al. De novo membranoproliferative glomerulonephritis in hepatitis C virus-infected renal allograft recipients. Transplantation 1995;59:1676-82.
10. Cantarell MC, Charco R, Capdevila L, et al. Outcome of hepatitis C virus-associated membranoproliferative glomerulonephritis after liver transplantation. Transplantation 1999;68:1131-4.
11. Burstein DM, Rodby RA. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. J Am Soc Nephrol 1993;4:1288-93.
12. Meyers CM, Seeff LB, Stehman-Breen CO, Hoofnagle JH. Hepatitis C and renal disease: An update. Am J Kidney Dis 2003;42:631-57.
13. Kovarik J, Mayer G, Pohanka E, et al. Adverse effect of low-dose prophylactic human recombinant leukocyte interferon-alpha treatment in renal transplant recipients. Cytomegalovirus infection prophylaxis leading to an increased incidence of irreversible rejection. Transplantation 1988;45:402-5.
14. Hanafusa T, Ichikawa Y, Kishikawa H, et al. Retrospective study on the impact of hepatitis C virus infection on kidney transplant patients over 20 years. Transplantation 1998;66:471-6.
15. Chan TM, Lok AS, Cheng IK, Ng IO. Chronic hepatitis C after renal transplantation. Transplantation 1993;56:1095-8.
16. Ichikawa Y, Kyo M, Hanafusa T, et al. A 20-year case study of a kidney transplant recipient with chronic active hepatitis C: Clinical course and successful treatment for late acute rejection induced by interferon therapy. Transplantation 1998;65:134-8.
17. Hirsch MS, Schooley RT, Cosimi AB, et al. Effects of interferon-alpha on cytomegalovirus reactivation syndromes in renal-transplant recipients. N Engl J Med 1983;308:1489-93.
18. Lui SF, Ali AA, Grundy JE, Fernando ON, Griffiths PD, Sweny P. Double-blind, placebo-controlled trial of human lymphoblastoid interferon prophylaxis of cytomegalovirus infection in renal transplant recipients. Nephrol Dial Transplant 1992;7:1230-7.
19. Baid S, Tolkoff-Rubin N, Saidman S, et al. Acute humoral rejection in hepatitis C-infected renal transplant recipients receiving antiviral therapy. Am J Transplant 2003;3:74-8.
20. Misiani R, Bellavita P, Fenili D, et al. Interferon alfa-2a therapy it cryoglobulinemia associated with hepatitis C virus. N Engl J Med 1994:330:751-6.
21. Yamabe H, Johnson RJ, Gretch DR, et al. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection responsive to interferon, alpha. Am J Kidney Dis 1995;25:67-9.
22. Sarac E, Bastacky S, Johnson JP. Response to high-dose interferon alpha after failure of standard therapy in MPGN associated with hepatitis C virus infection. Am J Kidney Dis 1997:30:113-5.
23. Radkowski M, Gallegos-Orozco JF, Jablonska J, et al. Persistence o Hepatitis C virus in patients successfully treated for chronic Hepatitis C. Hepatology 2005;41:106-14.
24. Durlik M, Gaciong Z, Rowinska D, et al. Long-term results of treatment of chronic hepatitis B,C and D with interferon-alpha in renal allograft recipients. Transpl Int 1998:11(Suppl 1):135-9.
25. Rostaing L, Modesto A, Baron E, Cisterne JM, Chabannier MH, Durand D. Acute renal failure in kidney transplant patients treated with interferon alpha 2b for chronic hepatitis C. Nephron 1996;74:512-6.
26. Kramer P, ten Kate FW, Bijnen AB, Jeekel J, Weimar W. Recombinant leukocyte interferon A induces steroid-resistant acute vascular rejection episodes in renal transplant recipients. Lancet 1984;1:989-90.
27. Tokumoto T, Tanabe K, Ichikawa T, et al. Effect of interferon-alpha treatment in hemodialysis patients and renal transplant recipients with chronic hepatitis C. Transplant Proc 1999;31:2887-9.
28. Ozgur O, Boyacioglu S, Telatar H, Haberal M. Recombinant alpha-interferon in renal allograft recipients with chronic hepatitis C. Nephrol Dial Transplant 1995;10:2104-6.
29. Takahara S, Kakimoto K, Kokado Y, et al. Interferon-alpha therap for chronic active hepatitis type C after renal transplantation and allograft rejection. Int Urol Nephro 1995;27:479-85.
30. Konishi I, Horiike N, Mitchitaka K, et al. Renal transplant recipient with chronic hepatitis C who obtained sustained viral response after interferon-beta therapy. Intern Med 2004;43:931-4.
31. Therret E, Pol S, Legendre CH, Gagnadoux MF, Cavalcanti R, Kreis H. Low-dose recombinant leukocyte interferon-alpha treatment of hepatitis C viral infection in renal transplant recipients. A pilot study. Transplantation 1994;58:625-628.
32. Tang S, Cheng IK, Leung VK, et al. Successful treatment of hepatitis C after kidney transplantation with combined interferon alpha-2b and ribavirin. J Hepatol 2003;39:875-8.
33. Magnone M, Holley JL, Shapiro R, et al. Interferon-alpha-induced acute renal allograft rejection. Transplantation 1994;59:1068-70.
34. Luciani G, Bossola M, Muscaritoli M, et al. Sustained response with negative serum HCV-mRNA and disappearance of antibodies after interferon-alpha therapy in a kidney transplant recipient with chronic active viral hepatitis C. J Nephrol 2003;16:417-20.